End-to-End Clinical Trial & CRO Services in Argentina
Empowering Your Growth in Argentina with All‑in‑One GxP and Regulatory Services
Argentina is emerging as a key market for pharmaceuticals, biotechnology, cosmetics, and nutraceuticals, driven by a strong industrial base and growing regional demand. To succeed, companies must align with the National Administration of Drugs, Food, and Medical Technology (ANMAT), which has recently adopted ICH E6(R3) GCP, harmonized GMP certification for foreign plants, and implemented Good Reliance Practices (GRP) to recognize international inspections.
Zenovel’s regulatory and scientific solutions help you ensure compliance, accelerate market entry, and maintain product quality and efficacy across Argentina’s dynamic life sciences landscape.
Good Clinical Practice (GCP) for Clinical Trial Compliance
We Ensure GCP Excellence for Compliant Clinical Trials Across Argentina
Clinical trials in Argentina are now governed by the National Administration of Drugs, Food, and Medical Technology (ANMAT) under a new Good Clinical Practices framework introduced by Disposition 7516/2025, published on October 9, 2025. This comprehensive regulation aligns with the ICH E6 (R3) guideline for clinical trials and became enforceable on December 1, 2025, effectively replacing the previous ANMAT Regulation 6677/2010.
Argentina’s 2024 status as a Regulatory Member of the ICH necessitates aligning national regulations with global standards. The adoption of ICH E6(R3) promotes a risk-based, quality-by-design approach for efficient clinical trials, specifically applicable to Phase I, II, and III studies for registration of new indications.
Zenovel provides GCP compliance services in Argentina to assist sponsors, CROs, and biotech firms in navigating the updated ANMAT regulatory framework.
Our GCP Compliance Services in Argentina Include the Following:
- Audit Support, Quality System Evaluation & Inspection Readiness
- Risk‑Based Compliance Assessments & Deviation Management
- Site Oversight, Vendor Compliance & CAPA Implementation
- Audit Trail Reviews & Documentation Control
At Zenovel, we collaborate with clinical and quality teams to create compliance frameworks that ensure inspection readiness. Utilizing our global regulatory expertise, we align with ANMAT, ICH E6(R3), and international standards to minimize compliance uncertainty, establishing ourselves as a trusted GCP compliance partner for clinical trials in Argentina.
Computer System Validation (CSV) in Argentina for Clinical Trial Compliance and Quality Assurance
ANMAT mandates the validation of computerized systems in GxP environments, as specified in Disposition 2819/2004, which requires that such systems, particularly those related to GMP, are reliable and compliant with national and international standards. Zenovel provides Computer System Validation (CSV) services in Argentina, supporting pharmaceutical, biotech, and clinical research organizations in aligning their GxP systems with ANMAT and international guidelines, including ICH, US 21 CFR Part 11, and GAMP 5 principles.
Our CSV Services in Argentina Include:
- Validation planning, risk assessment & IQ/OQ/PQ execution
- Lifecycle documentation for EDC, CTMS, LIMS, eTMF, and ERP platforms
- Data integrity, system controls & electronic record compliance, including alignment with ANMAT’s digital signature and electronic records framework
- Audit‑ready, scalable validation integrated with your quality strategy
Zenovel ensures systems are fully audit-ready and scalable, aligning with both Argentinian and global quality standards. By partnering with IT, QA, and clinical teams, it reduces validation delays, strengthens compliance, and enhances readiness for ANMAT audits and international reviews, thereby providing a reliable foundation for critical decision-making.
GCP Audit Services in Argentina for Clinical Trial Compliance & Quality Assurance
We Make Every Step Easier and Regulatory‑Compliant with Our GCP Audit Services in Argentina
Clinical trials in Argentina are governed by ANMAT under Disposition 7516/2025, which aligns with ICH E6(R3) guidelines for Good Clinical Practices, effective December 1, 2025. This regulation updates and replaces ANMAT 6677/2010, applying to Phase I, II, and III studies for drug registration or changes requiring clinical evidence. As an ICH regulatory member, Argentina enhances its compliance with global GCP standards.
Zenovel provides GCP audit services to assist sponsors, CROs, and investigative sites in addressing compliance issues before ANMAT evaluations.
Our GCP Audit Services in Argentina Include:
- Site audits, sponsor audits, vendor audits & system-level quality reviews
- Alignment with ICH E6(R3) guidelines, ANMAT Disposition 7516/2025, and WHO standards
- Assessment of protocol adherence, informed consent processes, documentation accuracy & data integrity
- CAPA development, risk‑based quality improvement & inspection readiness planning
Zenovel focuses on bridging compliance gaps in clinical operations to prepare organizations for ANMAT audits. With expertise in clinical quality assurance and GCP compliance in Argentina, Zenovel mitigates regulatory risks, enhances operational discipline, and bolsters sponsor trust, serving as a reliable partner for GCP audits and trial integrity.
CRO Set-up & Upgradation in Argentina for Maintaining GCP Compliance
We Establish Uncompromised GCP Compliance through Seamless CRO Setup.
Improving a CRO in Argentina necessitates compliance with ANMAT regulations and ICH E6(R3) GCP standards. Effective December 1, 2025, Argentina’s updated Disposition 7516/2025 formally adopts ICH E6(R3), emphasizing risk-based quality management and inspection readiness. Zenovel offers comprehensive support to ensure GCP compliance and operational excellence for new or existing CROs.
Our CRO Setup & Upgradation Services for GCP Compliance in Argentina Include:
- Operational framework design & quality management system (QMS) setup
- SOP development aligned with ANMAT, ICH E6(R3), and WHO GCP standards
- Risk‑based monitoring (RBM) integration & vendor management frameworks
- Inspection readiness planning & mock ANMAT GCP audit support
- Scalable, audit‑ready clinical trial infrastructure
At Zenovel, our experts collaborate with your clinical, QA, and regulatory teams to establish compliance systems that align with ANMAT standards and global benchmarks, ensuring your CRO remains inspection-ready and performance-focused from study start-up to close-out.
Pharmacokinetic Stat (PK-Stat) Solution for Data Compliance in Argentina
We Offer Reliable PK‑Stat Solutions for High‑Quality Clinical Research in Argentina
In clinical development, minor errors in pharmacokinetic interpretation can affect dosing, regulatory outcomes, and study credibility. Zenovel’s PK-Stat review services in Argentina offer precise pharmacokinetic analysis compliant with ANMAT regulations and international ICH standards, ensuring clinical data aligns with local and global regulatory expectations.
Our PK‑Stat Services in Argentina Include the Following:
- Non‑compartmental analysis (NCA) & population PK modeling
- PK/PD evaluation aligned with ANMAT and global expectations (FDA, EMA)
- Clinical biostatistics and data review for accuracy and validation
- CDISC compliance (SDTM/ADaM) & submission‑ready outputs
Zenovel’s expert team interprets data with a focus on scientific and regulatory standards, collaborating with clinical pharmacology and biostatistics teams to ensure data integrity and improve decision-making in trials. They are a trusted partner for PK-Stat and biostatistics in Argentina.
Pre‑Inspection Readiness Services in Argentina for GCP Compliance
We Assist You in Preparing Your Studies for Confident GCP Inspections in Argentina
Regulatory inspections are critical, highlighting the need for preparedness in clinical systems. Zenovel offers pre-inspection readiness services in Argentina to improve GCP compliance before audits, aligning with ANMAT and ICH guidelines. We help sponsors, CROs, and sites identify and mitigate compliance risks before ANMAT evaluations.
Our Pre‑Inspection Readiness Services in Argentina Include:
- Comprehensive gap assessments & mock regulatory inspections (ANMAT‑style)
- Documentation reviews & quality system evaluations
- Assessment of informed consent, protocol adherence, data integrity & vendor oversight
- CAPA effectiveness review & inspection response strategy
Zenovel improves quality management system (QMS) processes by simulating regulatory scrutiny and collaborating with clinical and quality teams, ensuring inspection success in the Argentine market. We offer a genuine readiness partnership for smooth transitions through regulatory inspections.
Risk‑Based Monitoring (RBM) Services in Argentina for Seamless Clinical Trials
We Enhance Clinical Monitoring with Stringent Data‑Driven RBM in Argentina
The introduction of Risk‑Based Monitoring (RBM) services in Argentina aims to overcome the shortcomings of traditional monitoring methods, which may hinder trials and miss essential risks. Zenovel’s approach prioritizes clinical oversight, patient safety, and data quality, aligning with the ANMAT, its updated Disposition 7516/2025 (adopting ICH E6(R3) for GCP), and international ICH guidelines.
Our services include:
- Centralized monitoring & key risk indicator (KRI) development
- Site risk assessment & real‑time data review strategies
- Alignment with ANMAT expectations and ICH E6(R3) guidelines
- Transition from routine on‑site to data‑driven, risk‑proportionate monitoring
Zenovel collaborates with clinical operations and data management teams to create risk-based monitoring plans that improve issue detection and trial efficiency in multi-site studies in Argentina. This approach supports early risk identification, resource optimization, and regulatory compliance, establishing Zenovel as a key partner for efficient clinical trials.
Sponsor Oversight Services in Argentina for Clinical Trial Governance
We improve clinical trial governance in Argentina by ensuring dependable oversight for sponsors.
Zenovel’s sponsor oversight services in Argentina provide comprehensive visibility, control, and accountability for trial sponsors, adhering to ANMAT’s Disposition 7516/2025 and international ICH guidelines, which facilitate enhanced oversight amidst multiple vendors, sites, and CROs.
Our Sponsor Oversight Services in Argentina Include:
- CRO performance oversight & vendor management
- Quality monitoring & risk‑based governance frameworks
- KPI tracking, responsibility mapping & consistent execution oversight
- Alignment with ICH E6(R3) guidelines and ANMAT expectations
Zenovel partners with sponsor teams to enhance quality systems, communication, and risk management in clinical trials in Argentina, offering expertise in governance, accountability, and inspection readiness for complex clinical operations.
Good Manufacturing Practice (GMP) Services in Argentina for Pharma Compliance
We assist pharmaceutical manufacturers in Argentina by ensuring their GMP standards and compliance.
In Argentina, pharmaceutical manufacturing is governed by ANMAT, adhering to Good Manufacturing Practice (GMP) standards in line with WHO and international guidelines. ANMAT is modernizing its GMP framework through the harmonization of certification for foreign plants and implementing Good Reliance Practices (GRP). Zenovel provides GMP services to help pharmaceutical and biotech companies achieve compliance and improve operational reliability.
Our GMP services in Argentina include the following:
- GMP audits, quality system (QMS) design & review
- Deviation management, CAPA implementation & documentation control
- Alignment with ANMAT, WHO GMP, PIC/S, and global standards
- Inspection readiness support & risk‑based compliance frameworks
Zenovel partners with quality and manufacturing teams to improve compliance systems and reduce risks, focusing on practical strategies that deliver tangible regulatory outcomes. We serve as a dependable GMP partner in Argentina for manufacturing and inspection-ready operations.
GMP Audit Services in Argentina for Maintaining Standardized Quality Check
We Ensure Products Meet Rigorous Safety and Efficacy Standards with GMP Audit Services in Argentina
Pharmaceutical manufacturing in Argentina is overseen by ANMAT, which enforces strict penalties for quality failures, such as production suspensions and license revocation. Zenovel provides GMP audit services in Argentina to help ensure compliance with ANMAT and international standards, including WHO GMP and PIC/S, through expert evaluations of manufacturing quality assurance.
Our GMP Audit Services in Argentina Include:
- Production processes & quality management systems (QMS)
- Documentation control, batch records & CAPA effectiveness
- Vendor quality systems & root cause analysis of compliance risks
- Alignment with current ANMAT provisions, WHO GMP, and PIC/S requirements
Zenovel considers audits as opportunities for regulatory intelligence, using experienced pharmaceutical quality assurance experts to improve manufacturing environments for ANMAT inspections or global regulatory evaluations. We serve as a GMP quality assurance partner in Argentina, boosting audit confidence through expert validation.
Pharma Plant Setup & Upgradation Services in Argentina
Advancing Pharmaceutical Facilities to Global and Regulatory‑Compliant GMP Standards in Argentina
Establishing or upgrading a pharmaceutical manufacturing facility in Argentina necessitates strict adherence to regulations from the ANMAT, including compliance with WHO GMP and PIC/S standards. Argentina’s full membership in PIC/S underscores the importance of aligning with global GMP expectations. Zenovel provides services for creating GMP-compliant, scalable, and inspection-ready manufacturing environments during the facility setup and upgrade processes in Argentina.
Our Pharma Plant Setup & Upgradation Services in Argentina Include:
- Plant design review, cleanroom classification & HVAC validation
- Equipment qualification (IQ/OQ/PQ) & QMS integration
- For existing facilities: modernization, gap closure, contamination control & process optimization
- Alignment with ANMAT, WHO GMP, PIC/S, and global standards
Zenovel enhances operational efficiency and compliance by leveraging engineering and regulatory expertise, specifically in preparation for ANMAT audits. Our team collaborates with manufacturing, QA, and validation teams to minimize regulatory risks and expedite processes.
Pre-inspection readiness services in Argentina for GMP Compliance
We Assist in GMP Inspection Readiness and Assure Compliance Confidence in Argentina
Regulatory inspections are crucial, with inadequate preparation potentially leading to findings, production delays, or license suspensions. Zenovel offers pre-inspection readiness services for GMP compliance in Argentina, ensuring that pharmaceutical manufacturing operations meet requirements set by ANMAT, WHO GMP, and PIC/S standards.
Our services involve:
- Gap analysis of quality systems, production processes & documentation
- Audit trail & CAPA system evaluation
- Mock ANMAT‑style inspections & GMP audit preparation
- Continuous compliance improvement for ANMAT and global regulatory alignment
We assist sponsors, CROs, and pharmaceutical sites in Argentina to enhance quality systems, reduce compliance risks, and effectively manage ANMAT inspections, ensuring preparedness before inspections.
Clinical & Scientific Expert Services in Argentina for Drug Development
We Offer Expert Clinical Insight Throughout Every Stage of Development in Argentina
Zenovel provides clinical expert services to pharmaceutical and biotech companies in Argentina, focusing on both early and late-stage drug development. Our support improves drug development strategies, refines study designs, and accelerates regulatory readiness, ensuring compliance with ANMAT regulations and ICH guidelines.
Our Clinical & Scientific Expert Services in Argentina Include:
- Clinical development strategy & protocol design
- PK/PD interpretation & translational science support
- Biomarker strategy, endpoint selection & study design optimization
- Regulatory scientific consulting aligned with ANMAT and global guidelines (FDA, EMA)
Zenovel collaborates with clinical, regulatory, and R&D teams to connect preclinical research with clinical execution, enhancing development efficiency and minimizing uncertainty through evidence-based recommendations. Zenovel is a dependable partner for science-driven drug development in Argentina.
Medical and Scientific Writing Services in Argentina for Regulatory Success
We offer regulatory-aligned documents to facilitate an easy review and approval process
Regulatory submissions in Argentina require accurate data and well-organized documentation to communicate effectively with ANMAT. Zenovel offers medical and scientific writing services to pharmaceutical, biotech, and CRO companies, converting complex clinical data into compliant submission documents in accordance with ANMAT standards and ICH guidelines, thus streamlining the approval process.
Our services include:
- Clinical study reports (CSR), protocols & investigator brochures (IB)
- Informed consent forms (ICF) & CTD/eCTD modules
- Pharmacovigilance documents & clinical summaries
- Full alignment with ICH guidelines and ANMAT regulatory standards
Zenovel merges scientific expertise with regulatory accuracy to produce organized documents that facilitate efficient reviews and approvals. It acts as an extension of regulatory and clinical teams, reducing documentation burdens and enhancing submission quality, thus establishing itself as a reliable medical writing partner in Argentina for swift, inspection-ready regulatory reviews.
Preclinical Support Services in Argentina for Early-Stage Drug Development
We streamline early drug development through expert preclinical support in Argentina
Zenovel provides preclinical support services in Argentina for biotech and pharmaceutical companies, assisting these companies in transitioning from discovery to clinical readiness. Our services combine scientific expertise with regulatory accuracy, producing reliable data packages that facilitate regulatory reviews and support successful IND submissions to ANMAT.
Our main Preclinical Support Services in Argentina include:
- In vitro & in vivo studies, toxicology assessment & PK/PD analysis
- Bioanalytical support & translational research
- Lead compound optimization, risk identification & safety evaluation
- Regulatory documentation aligned with ANMAT, Disposition 7516/2025 (adopting ICH E6(R3)), and global standards
Zenovel provides integrated CRO preclinical support services in Argentina, optimizing study design, minimizing delays and costs, and enhancing data accuracy. This facilitates quicker transitions to clinical phases while ensuring compliance with ANMAT, WHO GMP, PIC/S, and international standards for various therapies, positioning Zenovel as a reliable partner for clinical success in the region.
Regulatory Affairs & Compliance Services in Argentina for Global Submissions
Accelerating Global Submissions Through Regulatory Excellence Across Argentina
Navigating global regulations necessitates expertise. Zenovel’s Regulatory Affairs & Compliance Services in Argentina support pharmaceutical and biotech firms in product development and market authorization, facilitating submissions to ANMAT and international bodies like the FDA, EMA, and WHO.
Our Regulatory Affairs & Compliance Services in Argentina Include:
- eCTD dossier preparation, IND/CTA submissions & NDA/BLA support
- Labeling compliance, gap analysis, and regulatory intelligence
- Lifecycle management & post‑approval maintenance
- Alignment with ANMAT, ICH, PIC/S, and global guidelines
We offer regulatory compliance services in Argentina aimed at helping sponsors minimize submission delays and regulatory risks through an integrated approach that improves submission accuracy.
Dossier Due Diligence Services in Argentina for Regulatory Accuracy
We Assure That All Submissions Comply with Regulatory Standards in Argentina
A regulatory dossier may appear complete yet contain minor inconsistencies that delay review by ANMAT. Zenovel provides dossier due diligence services in Argentina, ensuring compliance with national and global regulatory standards through thorough CTD/eCTD dossier reviews.
Our Dossier Due Diligence Services in Argentina Include:
- Clinical data consistency & CMC documentation alignment
- Module integration & ICH guideline compliance
- Gap analysis for missing evidence, contradictions & formatting issues
- Submission risk assessment & quality assurance
- Alignment with ANMAT, PIC/S, and WHO requirements
Our regulatory experts enhance submission strategies by collaborating with clinical, and CMC teams, improving documentation clarity and coherence. This approach reduces submission risks, enhances quality assurance, and builds confidence during reviews by ANMAT and global health authorities, ensuring submissions are validated before reaching regulators in Argentina.
eCTD Compilation Services for Global Regulatory Submissions in Argentina
Serving You Argentina‑Based eCTD Expertise for Worldwide Regulatory Success
Optimize your regulatory approval in Argentina by utilizing expert eCTD compilation services, ensuring accurate electronic submissions that comply with ANMAT and international standards for faster market entry in the pharmaceutical, biotech, and life sciences sectors.
Our eCTD Compilation Services in Argentina Include:
- Document formatting, module‑wise structuring & quality validation
- Hyperlinking, publishing & submission readiness for ANMAT, PIC/S, and global authorities (FDA, EMA, WHO)
- IND, NDA, ANDA, and BLA dossier management for global filings
- Full compliance with evolving eCTD, ICH, and PIC/S guidelines (Argentina is a PIC/S member)
Zenovel specializes in global regulatory submissions, focusing on accuracy and efficiency to reduce errors and delays. This commitment enhances data integrity and expedites approval processes, establishing Zenovel as a reliable partner for electronic submissions in Argentina.
Environmental Risk Assessment Services for Regulatory Compliance in Argentina
Enhancing sustainability and mitigating potential environmental impacts through risk evaluations tailored to Argentine contexts
Pharmaceutical and biotech companies in Argentina must utilize Environmental Risk Assessment Services to meet regulatory requirements and ensure sustainable drug development. The ANMAT and international guidelines, like the EU Environmental Risk Assessment framework and WHO standards, stress the importance of conducting early evaluations of APIs and formulations for product approval and compliance.
Our services include:
- Phase I & Phase II environmental assessments
- PEC/PNEC calculations & exposure modeling
- Ecotoxicity evaluation & regulatory dossier preparation
- Integration with global submission strategies (ANMAT, PIC/S, WHO)
Integrating environmental compliance services early in development minimizes approval risks and delays, enhancing regulatory confidence for sponsors and CROs. Zenovel offers comprehensive documentation for global submissions and lifecycle compliance, establishing itself as a reliable partner for precise environmental assessments in Argentina.
EU QP Support Services for Batch Release Compliance in Argentina
Ensuring pharmaceutical products meet the stringent quality requirements necessary for market entry into the EU.
Ensuring regulatory compliance for Argentine pharmaceutical companies exporting to Europe requires EU QP Support Services, as Qualified Person (QP) certification is essential for compliance with GMP standards prior to product release in accordance with EU GMP Annex 16 requirements.
Our EU QP Support Services in Argentina include:
- Batch record review & GMP compliance verification
- Deviation assessment & quality documentation review
- Coordination with EU Qualified Persons for final certification
- Alignment with EU GMP Annex 16 and global regulatory expectations
- Support for Argentine manufacturers targeting EU markets under ANMAT export guidelines, WHO GMP, and PIC/S standards (Argentina is a full PIC/S member)
Zenovel provides expertise in batch release compliance to streamline product distribution in Europe, minimizing approval delays and compliance risks. Supporting Argentine pharmaceutical companies, CDMOs, and sponsors, our expert team acts as a reliable QP partner for adherence to EU regulatory standards.
Regulatory Gap Analysis Services in Argentina to comply with regulatory agencies
We assist in identifying compliance gaps and enhancing regulatory adherence
Regulatory Gap Analysis Services are required for pharmaceutical and biotech companies in Argentina to improve submission success and identify compliance gaps early. The service assesses clinical, non-clinical, and CMC documentation to ensure compliance with ANMAT, Disposition 7516/2025, PIC/S guidelines, and global standards, which are crucial for timely national and international approvals.
Our Regulatory Gap Analysis Services in Argentina Include:
- Dossier completeness & data integrity
- SOP compliance & submission readiness
- Gaps in IND, NDA, ANDA, and BLA applications (for global submissions)
- Actionable remediation plans for compliance optimization
- Alignment with ANMAT, PIC/S, ICH, and WHO requirements
Zenovel provides regulatory compliance readiness services that help sponsors reduce approval risks and enhance submission quality. We identify deficiencies and offer solutions to improve regulatory positioning, ensuring audit-ready, globally compliant documentation. Additionally, our team performs gap analysis in Argentina to prevent regulatory delays and facilitate approval-ready submissions.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
